StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was -202.3%, against -88.1% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-202.3%−114.1
FY2024Dec 31, 2024-88.1%–

More Scinai Immunotherapeutics figures

See a number that looks wrong?